Certain tactics in pharmaceutical marketing have tarnished the industry's reputation in recent times. Todd Evans of PwC looks at the new thinking that can help restore the public trust.
Bob Moore of GE Healthcare examines the benefits of contracting out scientific asset services.
Steffen Maennche, Principal Consultant with IMS Health, reveals the business benefits to be gained from diagnosing current incentive plans.
Jacco Keja, Managing Director and Practice Leader at Quintiles Consulting, Visiting Professor Life Sciences Pricing, Erasmus University, looks at the emerging opportunities for pharma companies in Europe.
Social media and the use of online technologies and practices has become an increasingly powerful communication tool that the pharmaceutical sector is just beginning to exploit.